Finance

Beta
Lists
RGNT:NYSEAMERICAN
Regentis Biomaterials Ltd
$1.89
-4.55%
(-0.090) 1D
May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGNT...
Open
$1.92
High
$1.93
Low
$1.80
Mkt. cap
9.79M
Avg. vol.
21.99K
Volume
0.00
52-wk high
$8.35
52-wk low
$1.80
EPS
-$24.08
Shares outstanding
5.18M
No. of employees
6
Open
$1.92
High
$1.93
Low
$1.80
Mkt. cap
9.79M
Avg. vol.
21.99K
Volume
0.00
52-wk high
$8.35
52-wk low
$1.80
EPS
-$24.08
Shares outstanding
5.18M
No. of employees
6
News stories
From sources across the web
About Regentis Biomaterials Ltd
CEO-
Employees6
Founded2004
Headquarters-
SectorBiotechnology
Websiteregentis.co.il
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
90.00K
90.00K
75.50K
75.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
129.50K
129.50K
3.19M
3.19M
Operating expense
219.50K
219.50K
3.26M
3.26M
Total operating expenses
219.50K
219.50K
3.26M
3.26M
Operating income
-219.50K
-219.50K
-3.26M
-3.26M
Other non operating income
-24.50K
-24.50K
-3.31M
-3.31M
EBT including unusual items
-1.61M
-1.61M
-5.21M
-5.21M
EBT excluding unusual items
-244.00K
-244.00K
-6.58M
-6.58M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.61M
-1.61M
-5.21M
-5.21M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-39.50K
-39.50K
Net interest expenses
-
-
-39.50K
-39.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer